Loring Wolcott & Coolidge Fiduciary Advisors LLP Boston Scientific Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,233 shares of BSX stock, worth $102,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,233
Previous 1,233
-0.0%
Holding current value
$102,721
Previous $84,000
11.9%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BSX
# of Institutions
1,448Shares Held
1.21BCall Options Held
8.14MPut Options Held
8.3M-
Vanguard Group Inc Valley Forge, PA130MShares$10.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.12 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.16 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.67 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $119B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...